Global Chiral Technology Market Report

April 11, 2014

DUBLIN, April 11, 2014 /PRNewswire/ –

Research and Markets (
http://www.researchandmarkets.com/research/zxblrf/global_chiral) has announced the
addition of the “Global Chiral Technology Market Report”
[http://www.researchandmarkets.com/research/zxblrf/global_chiral ] report to their
offering. <start_newscom>

(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

The analysts forecast the Global Chiral Technology market to grow at a CAGR of 14.53
percent over the period 2013-2017. One of the key factors contributing to this market
growth is the favorable governmental regulations. The Global Chiral Technology market has
also been witnessing the increasing outsourcing of pharmaceutical production to the APAC
Region. However, the complexity of chiral chemistry could pose a challenge to the growth
of this market.

The report, the Global Chiral Technology Market 2013-2017, has been prepared based on
an in-depth market analysis with inputs from industry experts. The report covers the
Americas, EMEA, APAC region; it also covers the Global Chiral Technology market landscape
and its growth prospects in the coming years. The report also includes a discussion of the
key vendors operating in this market.

Many global pharmaceutical companies are nowadays facing several challenges such as
patent expirations and pricing pressures. As a result, these companies are on the lookout
for cost containment measures. For instance, drug manufacturing in Asian countries is less
expensive than it is in western countries. Further, the growing prominence of Asia as an
end-user market and its growth in terms of manufacturing as well as human resource
capabilities is expected to contribute to the growth of the market during the forecast

According to the report, governmental regulations that support the use of chiral
technology constitute a major driver in this market. Healthcare authorities in many
countries have introduced guidelines and policies that provide incentives for investments
made in developing single enantiomer drugs.

Further, the report states that one of the main challenges in this market is the
complexity of chiral chemistry
[http://www.researchandmarkets.com/research/zxblrf/global_chiral ]. The complexity of
chiral chemistry is higher in the case of molecules containing multiple chiral centers. As
a result, the selection of an appropriate technique for the synthesis and resolution of
such molecules becomes challenging.

The report also includes a discussion of the other vendors operating in this market.
The other vendors in the market are Bachem Holding AG, Cambrex Corp., Codexis Inc, Johnson
Matthey plc, Novasep Inc., Phenomenex Inc., Regis Technologies Inc., Solvias AG, and Strem
Chemicals Inc.

The study was conducted using an objective combination of primary and secondary
information including inputs from key participants in the industry. The report contains a
comprehensive market and vendor landscape in addition to a SWOT analysis of the key

Key Topics Covered:

1. Executive Summary

2. Scope of the Report

3. Market Research Methodology

4. List of Abbreviations

5. Introduction

6. Market Landscape

7. Market Segmentation by Technology

8. Geographical Segmentation

9. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

17. Key Vendor Analysis

18. Other Reports in this Series

Companies Mentioned:

        - BASF SE
        - Bachem Holding AG
        - Cambrex Corp.
        - Codexis Inc.
        - Daicel Corp.
        - Johnson Matthey plc
        - Novasep Inc.
        - Phenomenex Inc.
        - Regis Technologies Inc.
        - Royal DSM N.V.
        - Solvias AG
        - Strem Chemicals Inc..

For more information visit


Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets

Source: PR Newswire

comments powered by Disqus